top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Myelostop 500 Capsule

Myelostop 500 Capsule

Manufacturer/Marketed By : SYMBION LIFE SCIENCE

$1.35 $0.88

Myelostop 500 Capsule is an anticancer medication containing the active ingredient as Hydroxyurea. It is used to treat chronic myeloid leukemia (cancer of white blood cells) and polycythemia vera (cancer...

HYDROXYUREA

Active Pharmaceutical Ingredient

Myelostop 500 Capsule

SKU MYELOSTOP-500-CAPSULE
Original price

$1.35

Sale price

$0.88

Myelostop 500 Capsule is an anticancer medication containing the active ingredient as Hydroxyurea. It is used to treat chronic myeloid leukemia (cancer of white blood cells) and polycythemia vera (cancer of red blood cells). The benefits of this medication include treating cancer by slowing down the growth and division of cancer cells and treating sickle cell anemia by reducing the frequency and severity of painful episodes and preventing organ damage. It is used to treat cervical, ovarian, and melanoma (skin cancer) and head and neck cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is used to treat sickle cell anemia (an inherited blood disease in which healthy red blood cells are insufficient). This medication may be used to treat other conditions not mentioned here. You need to talk to your physician if you have any blood disorders, severe anemia, kidney disorders, liver disorders, gout, leg ulcers, folic acid deficiency, or have an intolerance to some sugars before taking Myelostop 500 Capsules.

Active Pharmaceutical Ingredient

HYDROXYUREA

Uses

• Ovarian cancer
• Polycythemia vera
• Chronic myeloid leukemia
• Cervical cancer
• Head and neck cancer
• Sickle cell anemia

Benefits

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Side Effects

Like all medications, Myelostop 500 Capsule can cause side effects, although not everyone who takes it will experience them.

Most Common Side Effects

• Nausea
• Vomiting
• Diarrhea
• Loss of appetite
• Mouth sores
• Headache
• Dizziness
• Fatigue
• Skin darkening
• Hair loss or thinning
• Nail changes
• Constipation

Common Side Effects

• Bone marrow suppression (decreased blood cell count)
• Skin reactions (rash, itching, and skin ulcers)
• Stevens-Johnson syndrome (life-threatening skin reaction)
• Tumor lysis syndrome (occur when large numbers of cancer cells are killed rapidly)
• Liver damage (jaundice, dark urine, pale stools, nausea, vomiting, and abdominal pain)
• Lung toxicity (shortness of breath, cough, fever, and chest pain)

How To Use

To consume Myelostop 500 Capsule, shake the bottle well before each use to ensure the medicine is properly mixed. Measure the prescribed dose using the provided measuring cup or spoon. Take it by mouth, preferably after meals to reduce the risk of stomach upset. Follow your doctor’s instructions carefully regarding dosage and duration. Do not exceed the recommended dose, and consult your doctor if you miss a dose or experience any side effects.

Safety Advice

• Pregnancy: Myelostop 500 Capsule is not safe for use during pregnancy because it can harm to developing baby. You need to tell your physician if you are pregnant or planning to get pregnant before taking this medicine.
• Breast Feeding: It is not safe to take Myelostop 500 Capsules while breastfeeding. It has been shown to pass into breast milk, and its affects the nursing infant. Because of this, women who are taking this medication should avoid breastfeeding.
• Lungs: Myelostop 500 Capsules can cause lung toxicity, although this is a rare side effect. If you have pre-existing lung problems or a history of radiation therapy to the lungs, you should tell your healthcare provider before taking this medication.
• Liver: Myelostop 500 Capsule can potentially cause liver damage, although this is also a rare side effect. People who have pre-existing liver disease are at a higher risk. You need to tell your physician if you have any liver disorders before taking it, as this medication should be used with caution in liver disorder patients.
• Alcohol: Alcohol consumption can negatively affect the immune system and may interfere with the effectiveness of cancer therapies. So it is recommended to avoid taking alcohol while taking Myelostop 500 Capsule.
• Driving: Patients receiving Myelostop 500 Capsule should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page